about
Neuroendorine and Epigentic Mechanisms Subserving Autonomic Imbalance and HPA Dysfunction in the Metabolic SyndromeDepression contributing to dyslipidemic cardiovascular risk in the metabolic syndrome.Alcohol Use, Depression, and High-Risk Occupations Among Young Adults in the Ukraine.Efficacy and safety of agomelatine (10 or 25 mg/day) in non-depressed out-patients with generalized anxiety disorder: A 12-week, double-blind, placebo-controlled study.Anger Traits Associated With Cardiovascular Risk Biomarkers in the Metabolic Syndrome.Trait anxiety but not state anxiety level associates with biomarkers for hypertension in the metabolic syndrome.Aggressivity and hostility traits affect different cardiovascular risk profiles in the metabolic syndrome.Alexithymia as a risk factor for type 2 diabetes mellitus in the metabolic syndrome: a cross-sectional study.
P50
Q26752744-F9D44E25-4DDA-44B8-AFBE-BC2A3A1623A3Q33559285-A1129397-7631-419F-9061-D8BEE2B1C33FQ37154490-A83B41E6-ABDC-4F27-8113-1502DEDC0131Q38905258-46FB2480-CEC0-4944-87C0-71443A6C8ADCQ39684771-D4166366-82C2-4D0C-A9A8-F5DA96856856Q40933382-02B2AFE5-0E5B-4FAD-888F-033E54A7FB8CQ43883638-F440C94F-7E75-4626-9AB6-1146BF23819AQ51126221-C1EF0FCB-E308-4AE7-94E5-A160D7AE2F28
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0001-9702-7629
@en
name
Oleg Chaban
@ast
Oleg Chaban
@en
Oleg Chaban
@es
Oleg Chaban
@nl
type
label
Oleg Chaban
@ast
Oleg Chaban
@en
Oleg Chaban
@es
Oleg Chaban
@nl
prefLabel
Oleg Chaban
@ast
Oleg Chaban
@en
Oleg Chaban
@es
Oleg Chaban
@nl
P106
P1153
55974696300
P31
P496
0000-0001-9702-7629